BeiGene Oncology (ONC) Sof marja

BeiGene Ltd. (ONC) tovar belgisi

BeiGene Ltd kompaniyasining savdo marjasi Osiyo rivojlanishining samaradorligini va keyinchalik yuqori xarajatli onkologik dori vositalarining G'arb bozorlariga olib kirilishini namoyish etadi, bunda 13.90 ko'rsatkichi maqsadli daraja vazifasini o'taydi. Yuqori masshtablanish qobiliyati qimmatbaho sinovlar yakunlanganidan keyingi global taqsimot hisobiga ta'minlanadi. Kompaniyaning organik o'sishi dunyodagi eng yirik sog'liqni saqlash gigantlari bilan strategik sheriklikka tayanadi.

beigene.com (ONC) - Sof marja 04.07.2022dan 19.11.2026gacha

BeiGene Ltd (ONC) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning fundamental baholanishi:BeiGene Corp - ONC
BeiGene Oncology ishlab chiqargan mahsulot

John Euler rahbarligida AQSh va Xitoyda BeiGene Ltd. (ONC) mahsulotlarining agressiv tijoratlashtirilishi sof foyda marjasi grafigida yaqqol aks etgan. Ushbu ko'rsatkich sof daromadning umumiy tushumga nisbati sifatida hisoblanadi va sotuvlarning har bir dollari uchun haqiqiy daromad ulushini o'lchaydi, bu esa investorlarga biznesning operatsion samaradorligini hamda kapitalning kamayishi xatarlarini baholash imkonini beradi.

Muhim raqobatchilar

Halozyme Corp (HALO) - Sof marja|Sof marja Revolution Medicines Inc (RVMD)|Sof marja Ascentage Pharma Group|Sotuvning sof rentabelligi CGON (CG Oncology Corp)|Sof marja UroGen Pharma (URGN)|Sotuvning sof marjinal rentabelligi Bicara Therapeutics (BCAX)|Sotuvning sof marjinal rentabelligi PSNL (personalis.com)|Sof foyda normasi ERAS|DCTH: Sof foyda bo'yicha sotuv rentabelligi|YmAbs - Kompaniyaning sof rentabelligi|aurabiosciences.com (AURA) - Sof marja|Candel Therapeutics Inc. - Sof foyda normasi|Sof marja Accuray Inc.|Sof marja SELLAS Life Sciences Group SLS|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)